Arax Advisory Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-300
| Closed | -$266 | – | 1320 |
|
|
2022
Q4 | $266 | Sell |
300
-100
| -25% | -$89 | ﹤0.01% | 1228 |
|
|
2022
Q3 | $1K | Buy |
400
+100
| +33% | +$250 | ﹤0.01% | 1198 |
|
|
2022
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 1147 |
|
|
2022
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 1140 |
|
|
2021
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 863 |
|
|
2021
Q2 | $3K | Buy |
+300
| New | +$3K | ﹤0.01% | 825 |
|